Program EpiNantes 2018
IRS-UN, 8 quai Moncousu Nantes
Jean-Pierre Issa : Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, USA
Keynote lecture - Epigenetic therapy : bench to bedside
Silvia Anna Ciafrè : University of Rome, Italy
Long noncoding RNAs as powerful players in glioblastoma
Yegor Vassetzky : Institut Gustave Roussy, Villejuif, France
Viral proteins: epigenetic effectors of lymphomagenesis
Slimane Ait-si-ali : Epigénétique et destin cellulaire, Paris, France
Genomic and non-genomic roles of mammalian « histone » lysine methyltransferases during cell fate changes
Valentina Boeva : Computational (Epi-)Genetics of Cancer, Paris, France
Getting insights into neuroblastoma biology using computational analysis of histone modifications
Anaïs Bardet : Epigenetic regulation of cell identity, Illkirch, France
Transcription factor sensitivity to DNA methylation
Jorg Tost : Epigenetics and Environment (LEE), Paris, France
The impact of the environment and epignentics on inflammatory and autoimmune diseases
Dominique Guianvarc'h : Institut de Chimie Moléculaire et des Matériaux d'Orsay, Paris, France
Chemical tools for studying DNA and histone methylation
Lucia Altucci : Second University of Naples, Italy
Brd9 is critical in acute myeloid leukemia.
Sophie Lelièvre : Purdue University, IBCN, West Lafayette, USA
Risks-on-a-chip to determine the epigenetic effect of mediators of oxidative stress on the breast epithelium.
Pernette Verschure : Synthetic Systems Biology and Nuclear Organization, Amsterdam, The Nederlands
Dynamic epigenetic regulation: Single cells can make the difference
Marco Tomasetti : Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy
MiR-126 as epigenetic biomarker: from exposure to cancer development
Maria Gazouli : National & Kapodistrian University of Athens, Greece
Methylation Profiles of Cancer-related Genes at Circulating Tumor Cells Population: Implications in prognosis and diagnosis
CHEMICAL SESSION ORGANIZED BY COST- EpiChembio
Antonello Mai : Dipartimento di Chimica e Tecnologiedel Farmaco "Sapienza", Rome, Italy
Up and down in histone methylation: identification of first-in-class dual G9a/LSD1 inhibitors
Saulius Klimašauskas : Life Sciences Center, Vilnius University, Lithuania
Chemo-Enzymatic Approaches for Epigenomic Profiling of DNA
Manfred Jung : Institute of Pharmaceutical Sciences, Universität Freiburg, Germany
Chemical tools to interrogate reversible lysine acylation and methylation
Arasu Ganesan : University of East Anglia, Norwich Research Park, United Kingdom
What are HDAC inhibitors good for beyond t cell lymphomaµ?
